We’re proud to open our annual Request for Proposals on October 15, 2025, inviting innovators from Georgia Tech and Emory University to take their biomedical discoveries from the lab to real-world impact.
The application process is multi-stage: if selected to advance, you’ll prepare a full proposal outlining commercialization milestones and a corresponding budget, culminating in a pitch presentation to the Biolocity Oversight Committee.
At Biolocity, we’re not just funding ideas — we’re helping researchers bridge the gap from lab to market, and we can’t wait to see what innovations you’ll bring to the table.
Application Process
Phase 1:
-
Submit Video & Application along with Full Proposal: Submit a 3–5 minute lightning pitch video and project proposal along with your full application no later than December 1, 2025 (Download Biolocity Proposal Template HERE)
-
Oversight Committee Review: The Biolocity Team and Oversight Committee (OC) will review all submissions to select projects advancing to the next phase
-
Invitation to Phase 2: Selected projects are invited to work directly with the Biolocity team, developing their proposals and driving toward a successful pitch day
Phase 2:
-
Milestone & Budget Review: Participate in sessions to plan and refine your milestones and budget
-
Submit Full Proposal: Submit your completed full proposal to the Biolocity team
-
Pitch Coaching: Attend a full-pitch coaching session to prepare for your presentation
-
Final Pitch: Present your full pitch to the Oversight Committee (OC).
Eligibility
- Due to funding parameters this cycle, Georgia Tech–led proposals are limited to teams with a PI in the Wallace H. Coulter Department of Biomedical Engineering. Emory-led proposals remain open to all Emory departments.
- Intellectual property rights must be held (at least in part) by one of our partner institutions:
- Emory University
- Georgia Institute of Technology
- At least one principal investigator must be affiliated with Emory or Georgia Tech
- Technology must positively impact human health with compelling evidence for commercial potential
- Two principal investigators are preferred – one technical expert and one clinical expert
Funding Cycle Timeline

Evaluation Criteria
Technologies are evaluated based on the probability of future commercial success and the following criteria:
- Validity of unmet clinical need
- Competitive landscape
- Current and future market dynamics
- Strength and nature of intellectual property
- Addressability of regulatory risk
- Nature of reimbursement landscape
- High probability of attracting follow-on funding within 1-2 years of receiving an award
Email biolocity@gatech.edu with any questions regarding the application process.
You must be logged in to post a comment.